Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Department of Radiology, University of British Columbia, Vancouver, BC, Canada.
Acta Neurol Belg. 2021 Apr;121(2):331-339. doi: 10.1007/s13760-020-01577-y. Epub 2021 Jan 19.
Coronavirus disease (COVID-19) was first identified in late December 2019. The disease began in Wuhan, Hubei province in China and since then it has spread quickly to many countries all over the world. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was majorly seen to overwhelm the respiratory system with mild to severe acute respiratory syndrome considered pathognomic for the disease. However, with time a plethora of symptoms was observed in the patients infected with COVID-19 including strong evidence for neurological symptoms. Evidence suggests that the virus has both central and peripheral nervous system manifestations. Patients, particularly those who suffer from a severe illness, have a central nervous system (CNS) involvement and neurological manifestations. There is precise and targeted documentation of neurological symptoms with details of clinical, neurological, and electrophysiological findings. This review article thus gives an insight into the neuro-invasive potential of COVID-19 and discusses the possible pathogenesis.
新型冠状病毒病(COVID-19)于 2019 年 12 月下旬首次被确认。该疾病始于中国湖北省武汉市,此后迅速传播到世界许多国家。COVID-19 是由一种新型冠状病毒引起的,称为严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)。该病毒主要侵袭呼吸系统,轻度至重度急性呼吸综合征被认为是该病的特征性表现。然而,随着时间的推移,在感染 COVID-19 的患者中观察到了大量的症状,包括强烈的神经症状证据。有证据表明,该病毒具有中枢和外周神经系统表现。患者,特别是那些患有严重疾病的患者,中枢神经系统(CNS)受累和神经表现。有关于神经系统症状的精确和针对性的记录,详细描述了临床、神经和电生理发现。因此,这篇综述文章深入了解了 COVID-19 的神经侵袭潜力,并讨论了可能的发病机制。